Meritage Group’s Cardinal Health CAH Stock Holding History

Meritage Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,112	Closed	-$2.53M	–	29
2016 Q4	$2.53M	Buy	+35,112	New	+$2.54M	0.07%	33

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Meritage Group's CAH Position: Q1 2017 in Review

Meritage Group sold out of Cardinal Health (CAH) in Q1 2017, closing a stake of 35,112 shares — an estimated $2.53M sold.

Meritage Group first reported a position in CAH in Q4 2016 and held it in 1 quarter. The position peaked at $2.53M in Q4 2016. 767 funds tracked by Wall St. Rank hold CAH as of Q1 2017.

Meritage Group reported no remaining Cardinal Health position as of Q1 2017 after selling out during the quarter.
Meritage Group sold 35,112 Cardinal Health shares in Q1 2017, an estimated $2.53M.
Meritage Group first reported a position in Cardinal Health in Q4 2016 and held it in 1 quarter.
Meritage Group's Cardinal Health position peaked at $2.53M in Q4 2016.
767 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2017.

Based on Meritage Group's 13F filing for Q1 2017, filed 12 May 2017.